BIOVEGEN participates in the first meeting of the MEICOM project

BIOVEGEN participated last week in the first meeting of the MEICOM Project, which took place at the Institution of Engineering and Technology (IET) in Birmingham. The project, in which BIOVEGEN is involved as part of the Advisory Board, is aimed at improving the understanding of the control of meiotic recombination in plant crops.

The meeting served to bring together all the members participating in the project, which has a network of European research groups with an excellent collaborative history and training networks. BIOVEGEN participated as part of the advisory board with the presentation “BIOVEGEN – R&D network for plant Biotechnology” in which the role of the platform as a catalyst for public-private collaboration was presented and an analysis of R&D in the sector was carried out. agri-food.

MEICOM (Meiotic Control of Recombination in Crops) is a project funded by the Marie Sklodowska Curie Actions call for Horizon 2020 (H2020-MSCA-ITN-2017) whose objective is to create a team of 12 researchers to develop a cutting-edge approach to genetics. and molecular biology, all aimed at a better understanding of the control of meiotic recombination in plant crops.

• Announcement: H2020-MSCA-ITN-2017
• Budget: 3.107.819,88 €
• Participants:
  • 6 companies
  • 12 IPOs
  • 1 Platform